Machine learning identifies prognostic subtypes of the tumor microenvironment in non-small cell lung cancer

Machine Learning


  • Howlader, N. etc SEER Cancer Statistics Review, 1975-2017 Volume 4 (National Cancer Institute, 2020).

    Google Academic

  • Liao, G. etc Prognostic Role of Soluble Programmed Cell Death Ligand 1 in Non-Small Cell Lung Cancer: A Systematic Review and Meta-analysis. Front desk. Oncol. 11774131 (2021).

    Article CAS PubMed PubMed Central Google Scholar

  • Tubin, S., Khan, M. K., Gupta, S., Jeremic, B. Biology of NSCLC: Interactions between cancer cells, radiation, and the tumor immune microenvironment. cancer 13775 (2021).

    Article CAS PubMed PubMed Central Google Scholar

  • Barta, JA, Powell, CA, Wisnivesky, JP Global epidemiology of lung cancer. Anne Grove Health 852419 (2019).

    Google Academic

  • Howlader, N. etc Impact of advances in lung cancer treatment on population mortality. N. Engl. J. Med. 383640–649 (2020).

    Article CAS PubMed PubMed Central Google Scholar

  • Siegel, RL, Miller, KD, Jemal, A. Cancer Statistics, 2019. CA Cancer J. Clin. 697–34 (2019).

    Article PubMed Google Scholar

  • Varela, G. & Thomas, P. A. Surgical management of advanced non-small cell lung cancer. J. Solak. Dis. 6S217 (2014).

    PubMed PubMed Central Google Scholar

  • Miller, K.D. etc Cancer treatment and survival statistics 2019. CA Cancer J. Clin. 69363–385 (2019).

    Article PubMed Google Scholar

  • Goldstraw, P. etc Non-small cell lung cancer. Lancet 3781727–1740 (2011).

    Article Google Scholar

  • Tan, C. etc Development of an immunopathology-based radiomics model for non-small cell lung cancer. Scientific Representative 81–9 (2018).

    Advertisement Google Scholar

  • Azuma Isao etc Association between PD-L1 overexpression and activating EGFR mutations in surgically resected non-small cell lung cancer. Ann.Oncol. twenty five1935-1940 (2014).

    Article CAS PubMed Google Scholar

  • Meyers, D., Bryan, P., Banerji, S. & Morris, D. Targeting the PD-1/PD-L1 axis in the treatment of non-small cell lung cancer. Current Oncology twenty five324–334 (2018).

    Article Google Scholar

  • Gallon, E.B. etc Pembrolizumab for the treatment of non-small cell lung cancer. N. Engl. J. Med. 3722018–2028 (2015).

    Article PubMed Google Scholar

  • Brahma JR etc Safety and activity of anti-PD-L1 antibodies in patients with advanced cancer. N. Engl. J. Med. 3662455–2465 (2012).

    Article CAS PubMed PubMed Central Google Scholar

  • Glatzel Pluczynska, N. etc SATB1 levels correlate with Ki-67 expression and are a positive prognostic factor in non-small cell lung cancer. Anticancer Drug Research 38723–736 (2018).

    CAS PubMed Google Scholar

  • Pavelczyk, K. etc The role of PD-L1 expression in non-small cell lung cancer and its prognostic significance according to clinicopathological factors and diagnostic markers. International Journal of Molecular Science 20824 (2019).

    Article CAS PubMed PubMed Central Google Scholar

  • Masayuki Shimoji etc Clinical and pathological characteristics of programmed cell death ligand 1 (PD-L1)-expressing lung cancer. lung cancer 9869–75 (2016).

    Article PubMed Google Scholar

  • Sun, J.-M. etc Prognostic significance of PD-L1 in patients with non-small cell lung cancer: a large cohort study of surgically resected cases. J. Thoracic Oncology 111003–1011 (2016).

    Article CAS PubMed Google Scholar

  • Zhou, C. etc PD-L1 expression as a poor prognostic factor in patients with nonsquamous non-small cell lung cancer. Oncotarget 858457 (2017).

    Article PubMed PubMed Central Google Scholar

  • Cooper, Washington etc PD-L1 expression is a favorable prognostic factor in early stage non-small cell lung cancer. lung cancer 89181–188 (2015).

    Article PubMed Google Scholar

  • Teng, MW, Ngiow, SF, Ribas, A. & Smyth, MJ Classification of cancer based on T cell infiltration and PD-L1. Cancer Research 752139–2145 (2015).

    Article CAS PubMed PubMed Central Google Scholar

  • Guo, W., Ji, Y., Catenacci, D. V. Subgroup cluster-based Bayesian adaptive design for precision medicine. Biometric authentication 73367–377 (2017).

    Article MathSciNet PubMed Google Scholar

  • Fisher, R., Pusztai, L., Swanton, C. Cancer heterogeneity: implications for targeted therapy. Br. J. Cancer 108479–485 (2013).

    Article CAS PubMed PubMed Central Google Scholar

  • Dagogo-Jack, I. & Shaw, A. T. Tumor heterogeneity and resistance to cancer therapy. Journal of the National Society of Clinical Oncology 1581–94 (2018).

    Article CAS PubMed Google Scholar

  • Yu, D. etc Machine learning prediction of poor outcome in patients with non-traumatic subarachnoid hemorrhage. Ann. Clin. Transl. Neurol. 72178–2185 (2020).

    Article PubMed PubMed Central Google Scholar

  • Luo, W. etc Guidelines for developing and reporting machine learning predictive models in biomedical research: an interdisciplinary perspective. J. Med. Internet Research 18e323 (2016).

    Article PubMed PubMed Central Google Scholar

  • Sun, W., Jiang, M., Dang, J., Chang, P. & Yin, F.-F. Effect of machine learning methods on prediction of NSCLC overall survival based on radiomics analysis. Radiation Oncology 131–8 (2018).

    Article Google Scholar

  • Ou, F.-S., Michiels, S., Shyr, Y., Adjei, AA & Oberg, AL Biomarker discovery and validation: statistical considerations. J. Thoracic Oncology 16537–545 (2021).

    Article CAS PubMed PubMed Central Google Scholar

  • Heiden, B.T. etc Analysis of delayed surgical treatment and oncologic outcomes in clinical stage I non-small cell lung cancer. JAMA Network Open Foure2111613–e2111613 (2021).

    Article PubMed PubMed Central Google Scholar

  • Andersen, P. K. & Gill, R. D. Cox regression models for counting processes: a large sample study. Ann. Stat. Ten1100–1120 (1982).

    Article MathSciNet Google Scholar

  • Kalbfleisch, J.D. & Prentiss, R.L. Statistical analysis of failure time data (Wiley, 2011).

    Google Academic

  • Binder, H., Allignol, A., Schumacher, M., Beyersmann, J. Boosting for high-dimensional time-to-event data with competing risks. Bioinformatics twenty five890–896 (2009).

    Article CAS PubMed Google Scholar

  • Ishwaran, H., Kogalur, U.B., Blackstone, E.H. & Lauer, M.S. Random survival forests. Ann. Appl. Stat. 2841–860 (2008).

    Article MathSciNet Google Scholar

  • Yeager, B.C. etc Diagonal random survival forest. Ann. Appl. Stat. 131847–1883 ​​(2019).

    Article MathSciNet PubMed PubMed Central Google Scholar

  • Harrell, FE, Califf, RM, Pryor, DB, Lee, KL, Rosati, RA Assessing medical testing yield. Jammer 2472543–2546 (1982).

    Article PubMed Google Scholar

  • Lang, M. etc mlr3: A modern object-oriented machine learning framework for R. J. Open Source Software Four1903 (2019).

    Article Advertisement Google Scholar

  • Stephoven, DJ & Stephoven, MDJ Package 'missForest'. R package version 1 (2013).



  • Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *